Taken together, we speculate that CYP2E1/JNK is an essential therapeutic target for PM2.5-induced NAFLD and TF might be a natural product which could alleviate PM2.5-NAFLD associated hepatocyte damage via inhibiting CYP2E1/JNK. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.